Kiniksa Pharmaceuticals International plc (KNSA)
KNSA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$78.53
-0.90% on the day
Market cap
$6.1B
Mid cap
Revenue · 2025
$677.6M
+60.1% on 2024
Net income · 2025
$59.0M
8.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | KNSA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001730430 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | BERMUDA |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $677.6M |
| Net income | $59.0M |
| Operating income | $77.2M |
| Net margin | 8.7% |
| Operating margin | 11.4% |
| Revenue growth | +60.1% |
| Cash | $165.6M |
| Total assets | $763.6M |
| P/E (computed) | 103.8× |
| P/S (computed) | 9.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2024-06-28 |
| Latest annual report | 10-K | 2026-02-24 |
| Latest quarterly / interim | 10-Q | 2026-07-28 |
| Latest current report | 8-K | 2026-07-28 |
| Latest proxy | DEFA14A | 2026-04-16 |
Source: SEC EDGAR submissions feed, 763 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +1.6% |
| 1 month | +5.4% |
| 3 months | +29.7% |
| Year to date | +92.1% |
| 1 year | +114.0% |
| From 52-week high | -2.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BLTE | Belite Bio Inc | $151.87 | -4.24% | $6.1B |
| LGND | Ligand Pharmaceuticals Incorporated | $303.53 | -2.44% | $6.1B |
| RYTM | Rhythm Pharmaceuticals Inc. | $86.61 | -3.57% | $6.0B |
| ALKS | Alkermes plc | $39.73 | -1.32% | $6.7B |
| PRAX | Praxis Precision Medicines Inc. | $243.34 | -3.20% | $6.8B |
| AMRX | Amneal Pharmaceuticals Inc. | $19.57 | -2.30% | $6.8B |
| IONS | Ionis Pharmaceuticals Inc. | $42.38 | -2.95% | $7.0B |
| SYRE | Spyre Therapeutics Inc. | $80.45 | -6.34% | $7.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier